Quinzoline derivatives for use in the treatment of cancer
US7504408B2 · kind B2 · utility
7Cited by
7References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 4, 2003 |
| Grant date | Mar 17, 2009 |
| Priority date | — |
| Expiry date | Mar 29, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention concerns quinazoline derivatives of Formula (I)wherein each of Z, m, R1, n, R3, Z2 and R14 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive or anti-proliferative agent in the containment and/or treatment of solid tumour disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.